Ab&B Bio-Tech CO., LTD. JS Company Description

Ab&B Bio-Tech CO., LTD. JS engages in the research, development, manufacturing, and commercialization of vaccines in China. The company offers quadrivalent subunit influenza and trivalent subunit influenza vaccines.

Its product pipeline also includes lyophilized human rabies, pneumococcal polysaccharide vaccine 23, and recombinant zoster vaccine which is in phase I clinical trial; and adjuvanted quadrivalent subunit influenza, adjuvanted trivalent subunit influenza, recombinant RSV, mRNA mpox, mRNA respiratory syncytial virus (RSV), pneumococcal conjugate vaccine 24, live attenuated varicella, and tetanus toxoid adsorbed vaccines which is in preclinical trial.

The company was incorporated in 2015 and is headquartered in Taizhou, China.

Ab&B Bio-Tech CO., LTD. JS

Country	China
Founded	2015
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
CEO	Youcai An

Contact Details

Address: No. 32 Xinglin Road Taizhou, 225300 China
Phone	86 52 3868 19889
Website	abbbio.com

Stock Details

Ticker Symbol	2627
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000071P9
SIC Code	2834

Key Executives

Name	Position
Youcai An	GM and Executive Chairman
Yiming He	Assistant to the Chairman of Board and Executive Director
Jingyun Wu	Chief Financial Officer
Dr. Ze Chen	Deputy GM and Chief Scientist
Sio Ngo Lin	Joint Company Secretary
Jian Xu	Joint Company Secretary